Welcome to our dedicated page for Innoviva SEC filings (Ticker: INVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Innoviva鈥檚 story is told through royalties鈥攅very quarter the 10-Q reveals how inhaled respiratory therapies sold by its global partner translate into cash that powers new critical-care ventures. If you have searched for 鈥淚nnoviva SEC filings explained simply鈥� or wondered how milestone payments appear in an Innoviva annual report 10-K simplified, this page is your starting point.
Stock Titan layers AI onto each document so you can move from data to insight in minutes. Our platform pulls Innoviva Form 4 insider transactions real-time, highlights when directors buy ahead of royalty rate resets, and connects those moves to the numbers inside the 鈥淢anagement鈥檚 Discussion鈥� section. Use AI summaries to decode an 8-K鈥攕ee 鈥�Innoviva 8-K material events explained鈥� the moment a new licensing deal posts. Need a quick pulse on liquidity? Open the latest Innoviva quarterly earnings report 10-Q filing and let our engine surface free-cash-flow trends, collaboration expenses, and segment revenue.
- AI-powered takeaways that clarify complex royalty formulas
- AG真人官方-time alerts for Innoviva insider trading Form 4 transactions
- Side-by-side charts for 鈥�Innoviva earnings report filing analysis鈥�
- Plain-language answers for 鈥渦nderstanding Innoviva SEC documents with AI鈥�
- Quick links to the latest Innoviva proxy statement executive compensation
Whether you monitor 鈥�Innoviva executive stock transactions Form 4鈥� or track pipeline progress, Stock Titan turns dense filings into clear signals. Stay ahead with real-time feeds, concise AI commentary, and complete coverage of every form the company files.
Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation report beneficial ownership of 4,760,832 shares of Innoviva, Inc. common stock (CUSIP 45781M101), representing 7.56% of the outstanding class. The filing shows the reporting persons have sole voting and sole dispositive power over these shares. The statement is made on a Schedule 13G/A and includes a certification that the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. Certain funds managed by Renaissance may have rights to dividends or sale proceeds related to these securities.
Franklin Resources, Inc. and its principals Charles B. Johnson and Rupert H. Johnson, Jr. filed Amendment No. 2 to Schedule 13G on 08/01/2025 covering Innoviva, Inc. (INVA) common stock as of 06/30/2025.
- Ownership: 2,827,918 shares beneficially owned, equal to 4.5 % of outstanding shares.
- Control: Sole voting power 鈥� 2,583,688 shares; sole dispositive power 鈥� 2,827,918 shares; no shared voting or dispositive power.
- Threshold change: Item 5 confirms ownership has fallen to 鈥�5 percent or less,鈥� indicating the group is now below the 5 % reporting threshold.
- Reporting persons: Franklin Resources (DE), Charles B. Johnson, and Rupert H. Johnson, Jr.; all file as holding company/control persons (Type HC, CO/IN).
- Purpose: Securities are held in the ordinary course by investment鈥恗anagement subsidiaries; the filing states no intent to influence control of Innoviva.
The amendment mainly updates share counts and affirms that the institutional investor鈥檚 aggregate stake has decreased to a non-activist, sub-5 % level.
FAQ
What is the current stock price of Innoviva (INVA)?
What is the market cap of Innoviva (INVA)?
